Pharmacolog and Codonics extend existing agreement to include sales of WasteLog®
and associated services into Mexico
December 8, 2021. Pharmacolog and Codonics entered into a strategic agreement, appointing
Codonics as the exclusive distributor of WasteLog® in the American and Canadian markets one
year ago. Today, the company is announcing the agreement has been expanded to include
Codonics distribution of WasteLog® into Mexico. WasteLog® is an analytical tool that enables a
hospital pharmacy to assay narcotic waste to help prevent drug diversion.
The use of opioids in healthcare in Mexico has increased in the last decade, which has also led to
authorities pressuring healthcare providers to better control their narcotic drugs. This in turn has
led to a sharp increase in demand for systems that prevent narcotic medications from being
diverted. The combination of Codonics Safe Label System® (SLS) integrated with WasteLog®
provides a complete solution for fast, accurate identification and handling of narcotic drugs, and
has attracted great interest in Mexico.
“The amendment to our agreement with Codonics opens up an exciting market opportunity for
WasteLog®. As Mexico encounters an increased use of opiates, the demand for effective waste
screening systems has increased dramatically,” stated Mats Högberg, CEO, Pharmacolog.
“Furthermore, Codonics has vast experience doing business in Mexico with a substantial installed
base. Launching together with Codonics in Mexico means yet another growth opportunity for
Pharmacolog.”
“It is exciting to introduce the Wastelog product to healthcare providers in Mexico who are at the
forefront of medical care,” said Daniel Conde, Ph.D., Director of Regional Sales
EMEA/LAR, Codonics. “When integrated with Codonics Safe Label System®, it enables prepared
and wasted syringes to be scanned to quickly and easily to identify and record the returned
narcotic waste and close the loop on medication use, helping to prevent hospital drug diversion.”